论文部分内容阅读
2型糖尿病的发病逐年上升 ,并发症是糖尿病患者致残致死的主要原因 ,糖尿病肾病居首位。预防糖尿病肾病 (DN)的发生发展一直是学术界关注的热点 ,至今无确切可行的治疗方法。近年来对血管转换酶抑制剂 (ACEI)研究较多 ,对二酰基甘油 -蛋白激酶C(DAG -PKC)通路的抑制剂VitE研究
The incidence of type 2 diabetes is increasing year by year. The complication is the main cause of death caused by diabetes. Diabetic nephropathy ranks the first place. Preventing the occurrence and development of diabetic nephropathy (DN) has been a hot spot in academic circles, so far there is no feasible treatment. In recent years, there are many studies on angiotensin converting enzyme inhibitors (ACEIs), VitE study on the pathway of diacylglycerol-protein kinase C (DAG-PKC)